Post-treatment of melatonin with CCl4 better reduces fibrogenic and oxidative changes in liver than melatonin co-treatment

Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway

(2017) Liu-Ya Tang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Melatonin protects against lipid-induced mitochondrial dysfunction in hepatocytes and inhibits stellate cell activation during hepatic fibrosis in mice

(2017) Nabanita Das et al.   JOURNAL OF PINEAL RESEARCH

Inhibition of the SphK1/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells

(2016) Bárbara González-Fernández et al.   BIOFACTORS

Melatonin: the dawning of a treatment for fibrosis?

(2016) Wei Hu et al.   JOURNAL OF PINEAL RESEARCH

Melatonin protects female rats against steatosis and liver oxidative stress induced by oestrogen deficiency

(2016) Danielle Aparecida Munhos Hermoso et al.   LIFE SCIENCES

Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress

(2016) Memy H. Hassan et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Gingerol protects against experimental liver fibrosis in rats via suppression of pro-inflammatory and profibrogenic mediators

(2016) Mardi M. Algandaby et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Antioxidant and anti-inflammatory action of melatonin in an experimental model of secondary biliary cirrhosis induced by bile duct ligation

(2016) Josieli Raskopf Colares et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1β or TNF-α Release from Human Hepatic Stellate Cells

(2016) Sacha Robert et al.   PLoS One

Melatonin, quercetin and resveratrol attenuates oxidative hepatocellular injury in streptozotocin-induced diabetic rats

(2015) H Elbe et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Protective Role of Melatonin in Liver Damage

(2014) Cezary Chojnacki et al.   CURRENT PHARMACEUTICAL DESIGN

Superoxide anion radicals activate hepatic stellate cells after entry through chloride channels: A new target in liver fibrosis

(2014) Gertjan J.M. den Hartog et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Diallyl trisulfide attenuates carbon tetrachloride-caused liver injury and fibrogenesis and reduces hepatic oxidative stress in rats

(2014) Xiaojing Zhu et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Antifibrotic activity of hesperidin against dimethylnitrosamine-induced liver fibrosis in rats

(2014) Shimaa M. Elshazly et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Melatonin: Exceeding Expectations

(2014) Russel J. Reiter et al.   PHYSIOLOGY

The antioxidant effect of β-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation

(2012) Miguel Angel Calleja et al.   BRITISH JOURNAL OF NUTRITION

Melatonin attenuates oxidative stress, liver damage and hepatocyte apoptosis after bile-duct ligation in rats

(2012) Cevat Aktas et al.   TOXICOLOGY AND INDUSTRIAL HEALTH

The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91phox mediate hepatic fibrosis in mice

(2011) Yong-Han Paik et al.   HEPATOLOGY

Comparison of vitamin E, L-carnitine and melatonin in ameliorating carbon tetrachloride and diabetes induced hepatic oxidative stress

(2010) M. E. Shaker et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Inhibition of carbon tetrachloride–mediated apoptosis and oxidative stress by melatonin in experimental liver fibrosis

(2008) M Ogeturk et al.   TOXICOLOGY AND INDUSTRIAL HEALTH